HK1243422A1 - 三草癌菌素dc-45-a2的全合成及三草癌菌素类似物的制备 - Google Patents
三草癌菌素dc-45-a2的全合成及三草癌菌素类似物的制备 Download PDFInfo
- Publication number
- HK1243422A1 HK1243422A1 HK18102899.8A HK18102899A HK1243422A1 HK 1243422 A1 HK1243422 A1 HK 1243422A1 HK 18102899 A HK18102899 A HK 18102899A HK 1243422 A1 HK1243422 A1 HK 1243422A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- trioxacarcin
- analogs
- preparation
- total synthesis
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462094662P | 2014-12-19 | 2014-12-19 | |
| US62/094,662 | 2014-12-19 | ||
| US201562186128P | 2015-06-29 | 2015-06-29 | |
| US62/186,128 | 2015-06-29 | ||
| PCT/US2015/066703 WO2016100833A2 (en) | 2014-12-19 | 2015-12-18 | Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1243422A1 true HK1243422A1 (zh) | 2018-07-13 |
Family
ID=56127867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK18102899.8A HK1243422A1 (zh) | 2014-12-19 | 2015-12-18 | 三草癌菌素dc-45-a2的全合成及三草癌菌素类似物的制备 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US10899773B2 (enExample) |
| EP (1) | EP3233877A4 (enExample) |
| JP (1) | JP2017537968A (enExample) |
| KR (1) | KR20170122718A (enExample) |
| CN (1) | CN107250144A (enExample) |
| AU (1) | AU2015364347A1 (enExample) |
| BR (1) | BR112017013194A2 (enExample) |
| CA (1) | CA2970955A1 (enExample) |
| CL (1) | CL2017001599A1 (enExample) |
| CO (1) | CO2017007074A2 (enExample) |
| CR (1) | CR20170331A (enExample) |
| DO (1) | DOP2017000144A (enExample) |
| EA (1) | EA201791388A1 (enExample) |
| EC (1) | ECSP17046657A (enExample) |
| GT (1) | GT201700139A (enExample) |
| HK (1) | HK1243422A1 (enExample) |
| IL (1) | IL252947A0 (enExample) |
| MA (1) | MA41216A (enExample) |
| MX (1) | MX2017008162A (enExample) |
| PE (1) | PE20171787A1 (enExample) |
| PH (1) | PH12017501147A1 (enExample) |
| SG (1) | SG11201704935XA (enExample) |
| WO (1) | WO2016100833A2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019036537A1 (en) * | 2017-08-17 | 2019-02-21 | William Marsh Rice University | ANALOGUES AND DIMER OF TRIOXACARCIN AS POWERFUL ANTICANCER AGENTS |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5815995A (ja) | 1981-07-22 | 1983-01-29 | Kyowa Hakko Kogyo Co Ltd | Ｄｃ−４５−ａ↓１およびｄｃ−４５−ａ↓２ならびにそれらの製造法 |
| EP0157203A3 (en) * | 1984-04-04 | 1986-10-01 | American Cyanamid Company | Antitumor agents ll-d49194 alpha 1, ll-d49194 beta, ll-d49194 beta 2, ll-d49194 upsilon, ll-d49194 delta, ll-d49194 epsilon, ll-d49194 zeta, and ll-d49194 eta |
| JPS63135389A (ja) * | 1986-11-26 | 1988-06-07 | Kyowa Hakko Kogyo Co Ltd | Ｄｃ−４５類の誘導体 |
| US9102697B2 (en) | 2010-03-22 | 2015-08-11 | President And Fellows Of Harvard College | Trioxacarcins and uses thereof |
| US9775915B2 (en) * | 2012-11-26 | 2017-10-03 | President And Fellows Of Harvard College | Trioxacarcins, trioxacarcin-antibody conjugates, and uses thereof |
-
2015
- 2015-12-17 MA MA041216A patent/MA41216A/fr unknown
- 2015-12-18 CR CR20170331A patent/CR20170331A/es unknown
- 2015-12-18 AU AU2015364347A patent/AU2015364347A1/en not_active Abandoned
- 2015-12-18 MX MX2017008162A patent/MX2017008162A/es unknown
- 2015-12-18 CA CA2970955A patent/CA2970955A1/en not_active Abandoned
- 2015-12-18 US US15/537,319 patent/US10899773B2/en active Active
- 2015-12-18 CN CN201580076346.2A patent/CN107250144A/zh active Pending
- 2015-12-18 PE PE2017001101A patent/PE20171787A1/es unknown
- 2015-12-18 EA EA201791388A patent/EA201791388A1/ru unknown
- 2015-12-18 BR BR112017013194-3A patent/BR112017013194A2/pt not_active Application Discontinuation
- 2015-12-18 HK HK18102899.8A patent/HK1243422A1/zh unknown
- 2015-12-18 EP EP15871176.2A patent/EP3233877A4/en not_active Withdrawn
- 2015-12-18 WO PCT/US2015/066703 patent/WO2016100833A2/en not_active Ceased
- 2015-12-18 JP JP2017532666A patent/JP2017537968A/ja not_active Withdrawn
- 2015-12-18 KR KR1020177020092A patent/KR20170122718A/ko not_active Withdrawn
- 2015-12-18 SG SG11201704935XA patent/SG11201704935XA/en unknown
-
2017
- 2017-06-15 IL IL252947A patent/IL252947A0/en unknown
- 2017-06-19 DO DO2017000144A patent/DOP2017000144A/es unknown
- 2017-06-19 GT GT201700139A patent/GT201700139A/es unknown
- 2017-06-19 PH PH12017501147A patent/PH12017501147A1/en unknown
- 2017-06-19 CL CL2017001599A patent/CL2017001599A1/es unknown
- 2017-07-14 CO CONC2017/0007074A patent/CO2017007074A2/es unknown
- 2017-07-19 EC ECIEPI201746657A patent/ECSP17046657A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PE20171787A1 (es) | 2017-12-28 |
| EA201791388A1 (ru) | 2017-11-30 |
| EP3233877A2 (en) | 2017-10-25 |
| IL252947A0 (en) | 2017-08-31 |
| MA41216A (fr) | 2017-10-24 |
| CA2970955A1 (en) | 2016-06-23 |
| WO2016100833A3 (en) | 2017-01-05 |
| BR112017013194A2 (pt) | 2018-01-02 |
| US10899773B2 (en) | 2021-01-26 |
| SG11201704935XA (en) | 2017-07-28 |
| GT201700139A (es) | 2018-10-24 |
| WO2016100833A2 (en) | 2016-06-23 |
| CO2017007074A2 (es) | 2017-10-20 |
| CN107250144A (zh) | 2017-10-13 |
| PH12017501147A1 (en) | 2018-03-05 |
| EP3233877A4 (en) | 2018-10-17 |
| JP2017537968A (ja) | 2017-12-21 |
| ECSP17046657A (es) | 2019-03-29 |
| MX2017008162A (es) | 2018-03-06 |
| KR20170122718A (ko) | 2017-11-06 |
| CL2017001599A1 (es) | 2018-11-09 |
| US20190023717A1 (en) | 2019-01-24 |
| DOP2017000144A (es) | 2017-09-29 |
| AU2015364347A1 (en) | 2017-07-13 |
| CR20170331A (es) | 2017-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12019500599A1 (en) | Sweet flavor modifier | |
| EP3481402A4 (en) | CONNECTIONS, COMPOSITIONS AND METHODS FOR TREATING A DISEASE | |
| MX2016016143A (es) | Compuestos de [1,2,4]triazol sustituido. | |
| HK1245019A1 (zh) | 吡啶酰胺化合物作爲杀真菌剂的用途 | |
| JO3155B1 (ar) | معدِّل نكهة حلوة | |
| EP3484504A4 (en) | COMPOUNDS, COMPOSITIONS AND METHODS OF TREATMENT OF DISEASE | |
| WO2015195656A3 (en) | Synthesis of polycyclic-carbamoylpyridone compounds | |
| SG10201908839QA (en) | 2,4-dihydroxy-nicotinamides as apj agonists | |
| EP3204386A4 (en) | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | |
| HK1248069A1 (zh) | 去乙酰氧基微管溶素h及其类似物 | |
| EA201692525A1 (ru) | Замещенные соединения [1,2,4]триазола и имидазола в качестве фунгицидов | |
| EA033460B1 (ru) | Замещенные [1,2,4]триазольные соединения в качестве фунгицидов | |
| MX2019005855A (es) | Formulaciones que se pueden pulverizar. | |
| MY180844A (en) | Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions | |
| MX2018000515A (es) | Compuestos fluorados de cbd, composiciones y usos de los mismos. | |
| TN2016000177A1 (en) | P-substituted asymmetric ureas and medical uses thereof | |
| EP3288636A4 (en) | COMPOSITIONS FOR THE TREATMENT OF EPISTAXIS | |
| HK1254231A1 (zh) | 米托-和厚朴酚化合物及其合成方法和用途 | |
| HK1255221A1 (zh) | 使用卡多曲组合物进行治疗的方法 | |
| MX371158B (es) | Compuestos inhibidores de pde2. | |
| WO2015111004A3 (en) | Improved process for the preparation of chlorophenyl trifluoroethanone | |
| PH12017501869A1 (en) | (s)-2'-vinyl-abscisic acid derivatives | |
| HK1250020A1 (zh) | 用於吡咯连接的二价化合物的化学合成的方法及其组合物 | |
| PH12016502592A1 (en) | 3'-substituted-abscisic acid derivatives | |
| HK1243422A1 (zh) | 三草癌菌素dc-45-a2的全合成及三草癌菌素类似物的制备 |